why choose us

First received: October 16, 2023

Clinical Trial: A Study of Deucravacitinib to Treat LPP and FFA

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lichen Planopilaris

Study Type: INTERVENTIONAL


Official Title: Deucravacitinib (BMS-986165) in the Treatment of Lichen Planopilaris

Brief Summary: The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.

Read more